Literature DB >> 13406745

Pain-producing substance in human inflammatory exudates and plasma.

D ARMSTRONG, J B JEPSON, C A KEELE, J W STEWART.   

Abstract

Entities:  

Keywords:  EXUDATES AND TRANSUDATES

Mesh：

Year:  1957        PMID： 13406745      PMCID： PMC1358839          DOI： 10.1113/jphysiol.1957.sp005715

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  13 in total

1.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor.

Authors:  D L WILHELM; A A MILES; M E MACKAY
Journal:  Br J Exp Pathol       Date:  1955-02

2.  Pharmacology of indole-alkylamines.

Authors:  V ERSPAMER
Journal:  Pharmacol Rev       Date:  1954-12       Impact factor: 25.468

3.  The mechanism of the functional hyperaemia in the submandibular salivary gland.

Authors:  S M HILTON; G P LEWIS
Journal:  J Physiol       Date:  1955-08-29       Impact factor: 5.182

4.  The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog.

Authors:  A H AMIN; T B CRAWFORD; J H GADDUM
Journal:  J Physiol       Date:  1954-12-10       Impact factor: 5.182

5.  Drugs which antagonize 5-hydroxytryptamine.

Authors:  J H GADDUM; K A HAMEED
Journal:  Br J Pharmacol Chemother       Date:  1954-06

6.  The effect of intravenous infusions of histamine on the urinary histamine and on gastric secretion in man.

Authors:  H M ADAM; W I CARD; M J RIDDELL; M ROBERTS; J A STRONG
Journal:  Br J Pharmacol Chemother       Date:  1954-03

7.  Inflammation and its control; a biochemical approach.

Authors:  G UNGAR
Journal:  Lancet       Date:  1952-10-18       Impact factor: 79.321

8.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

9.  Observations upon thermal burns: the influence of moderate temperature burns upon a proteinase of skin.

Authors:  A Beloff; R A Peters
Journal:  J Physiol       Date:  1945-03-28       Impact factor: 5.182

10.  The preparation and function of the hypertensin-converting enzyme.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307
View more
  60 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

3.  AN INCREASE IN BUTANOL-EXTRACTABLE 5-HYDROXY-TRYPTAMINE IN VENOUS BLOOD DURING REACTIVE HYPERAEMIA.

Authors:  E W HORTON
Journal:  J Physiol       Date:  1964-01       Impact factor: 5.182

4.  KININ FORMATION BY PLASMIN, AN INDIRECT PROCESS MEDIATED BY ACTIVATION OF KALLIKREIN.

Authors:  W VOGT
Journal:  J Physiol       Date:  1964-01       Impact factor: 5.182

5.  A STABLE SUBSTRATE FOR THE ASSAY OF PLASMA KININ-FORMING ENZYMES.

Authors:  E AMUNDSEN; K NUSTAD; B WAALER
Journal:  Br J Pharmacol Chemother       Date:  1963-12

6.  ON THE ANTI-INFLAMMATORY ACTIVITY OF PROTAMINE SULPHATE AND OF HEXADIMETHRINE BROMIDE, INHIBITORS OF PLASMA KININ FORMATION.

Authors:  D N KELLETT
Journal:  Br J Pharmacol Chemother       Date:  1965-06

7.  The inflammatory response.

Authors:  W G SPECTOR; D A WILLOUGHBY
Journal:  Bacteriol Rev       Date:  1963-06

8.  [Recent results in the field of plasma kinins].

Authors:  I TRAUTSCHOLD; G RUDEL
Journal:  Klin Wochenschr       Date:  1963-04-01

9.  Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

10.  Bradykinin initiates cytokine-mediated inflammatory hyperalgesia.

Authors:  S H Ferreira; B B Lorenzetti; S Poole
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.